Medical Hypotheses
Volume 61, Issue 5 , Pages 567-573, November 2003

Hyperinsulinemia may boost both hematocrit and iron absorption by up-regulating activity of hypoxia-inducible factor-1α

  • M.F McCarty

      Affiliations

    • Corresponding Author InformationCorrespondence to: Mark F. McCarty, Pantox Laboratories, 4622 Santa Fe St., San Diego, CA 92109, USA

Pantox Laboratories, San Diego, California, USA

Received 3 April 2002; accepted 12 July 2002.

Abstract 

There is growing evidence that increases in both hematocrit and body iron stores are components of the insulin resistance syndrome. The ability of insulin and of IGF-I – whose effective activity is increased in the context of insulin resistance – to boost activity of the transcription factor hypoxia-inducible factor-1α (HIF-1α), may be at least partially responsible for this association. HIF-1α, which functions physiologically as a detector of both hypoxia and iron-deficiency, promotes synthesis of erythropoietin, and may also mediate the up-regulatory impact of hypoxia on intestinal iron absorption. Insulin/IGF-I may also influence erythropoiesis more directly, as they are growth factors for developing reticulocytes. Conversely, the activation of HIF-1α associated with iron deficiency may be responsible for the increased glucose tolerance noted in iron-deficient animals; HIF-1α promotes efficient glucose uptake and glycolysis – a sensible adaptation to hypoxia – by inducing increased synthesis of glucose transporters and glycolytic enzymes. Recent reports that phlebotomy can increase the efficiency of muscle glucose uptake in lean healthy omnivores are intriguing and require further confirmation. Whether increased iron stores contribute to the elevated vascular risk associated with insulin resistance is doubtful, inasmuch as most prospective studies fail to correlate serum ferritin or transferrin saturation with subsequent vascular events. However, current data are reasonably consistent with the possibility that moderately elevated iron stores are associated with increased overall risk for cancer – and for colorectal cancer in particular; free iron may play a catalytic role in ‘spontaneous’ mutagenesis. Thus, iron excess may mediate at least some of the increased cancer risk associated with insulin resistance and heme-rich diets. People who are insulin resistant can minimize any health risk associated with iron overload by avoiding heme-rich flesh foods and donating blood regularly.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-9877(03)00231-7

doi:10.1016/S0306-9877(03)00231-7

Medical Hypotheses
Volume 61, Issue 5 , Pages 567-573, November 2003